IMV Inc. (IMV) Names Kyle Kuvalanka to Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. AVGO
3. CDNS
4. ANT
5. BA
6. SPY
7. META
8. HOOD
9. INTC
10. JBLU

Go back to IMV Inc. (IMV) Names Kyle Kuvalanka to Board

IMV Appoints Kyle Kuvalanka to Board of Directors

March 25, 2021 7:05 AM EDT

IMV to leverage Mr. Kuvalankas industry expertise as it advances its lead immunotherapy toward potential registration and commercialization

Company advancing novel immunotherapies in oncology and infectious diseases built on its proprietary DPX platform with novel lipid-based delivery technology

Wayne Pisano to retire after 10 years as a Board member

DARTMOUTH, Nova Scotia--(BUSINESS WIRE)-- IMV Inc. (the "Company" or "IMV") (NASDAQ: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of immunotherapies, today announced the... More